Participants 41 154 3
patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan
Participants 513 729 8
Nineteen patients with extremity melanoma (n = 16) or sarcoma (n = 3), underwent 90-minute ILP with TNF-alpha, interferon gamma (0.2 mg), and M (10 to 13 mg/L of limb volume) (TNF/IFN/M) (n = 12), or M alone (n = 7).
